Campbell & Co Investment Adviser’s Medifast MED Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,420	Closed	-$194K	–	1327
2025 Q1	$194K	Sell	14,420 -11,925	-45%	-$179K	0.01%	946
2024 Q4	$464K	Buy	+26,345	New	+$489K	0.04%	690
2024 Q3	–	Sell	-51,546	Closed	-$1.12M	–	1236
2024 Q2	$1.12M	Sell	51,546 -17,080	-25%	-$455K	0.1%	319
2024 Q1	$2.63M	Buy	+68,626	New	+$3.32M	0.23%	86
2023 Q2	–	Sell	-4,901	Closed	-$508K	–	1029
2023 Q1	$508K	Buy	+4,901	New	+$543K	0.09%	413
2022 Q4	–	Sell	-12,842	Closed	-$1.39M	–	907
2022 Q3	$1.39M	Buy	+12,842	New	+$1.84M	0.32%	59
2020 Q4	–	Sell	-2,200	Closed	-$362K	–	515
2020 Q3	$362K	Buy	+2,200	New	+$362K	0.27%	140
2018 Q4	–	Sell	-1,100	Closed	-$244K	–	435
2018 Q3	$244K	Buy	+1,100	New	+$223K	0.17%	286
2018 Q2	–	Sell	-2,992	Closed	-$280K	–	469
2018 Q1	$280K	Hold	2,992	–	–	0.24%	187
2017 Q4	$209K	Buy	+2,992	New	+$198K	0.15%	309
2016 Q1	–	Sell	-7,906	Closed	-$240K	–	142
2015 Q4	$240K	Buy	7,906 +394	+5%	+$11.7K	1.6%	25
2015 Q3	$202K	Buy	+7,512	New	+$219K	0.13%	273

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Campbell & Co Investment Adviser's MED Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Medifast (MED) in Q2 2025, closing a stake of 14,420 shares — an estimated $194K sold.

Campbell & Co Investment Adviser first reported a position in MED in Q3 2015 and held it in 12 quarters. The position peaked at $2.63M in Q1 2024. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

Campbell & Co Investment Adviser reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 14,420 Medifast shares in Q2 2025, an estimated $194K.
Campbell & Co Investment Adviser first reported a position in Medifast in Q3 2015 and held it in 12 quarters.
Campbell & Co Investment Adviser's Medifast position peaked at $2.63M in Q1 2024.
120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.